Kyleena 19.5 MG systems
Ended Awarded
- Contract number
- SPE2DB26FD1BF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,718
Award facts
- Contract value 100% obligated
- $3,718.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,718.20 to DMS Pharmaceutical Group Inc. for Kyleena 19.5 mg contraceptive systems, effective October 28, 2025, with completion targeted for November 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received this firm fixed-price delivery order without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The award represents a single transaction under the company's broader pharmaceutical supply agreement with the federal government.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy supporting Department of Defense medical supply requirements worldwide. The parent IDC, awarded November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As a regional prime vendor contractor, DMS Pharmaceutical Group supplies an extensive portfolio of branded and generic pharmaceuticals, biologics, and medical consumables to military healthcare facilities globally, with this particular delivery order for contraceptive devices reflecting the company's role in supporting diverse specialized pharmaceutical needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FD1BF?
SPE2DB26FD1BF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FD1BF worth?
The government has obligated $3,718 on SPE2DB26FD1BF.
Is contract SPE2DB26FD1BF an order under another contract?
Yes. SPE2DB26FD1BF is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB26FD1BF competed?
The extent of competition for SPE2DB26FD1BF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award